Original Research
Published on 16 May 2024
Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibition
in Cancer Cell Signaling
- 273 views
Original Research
Published on 16 May 2024
in Cancer Cell Signaling
Review
Accepted on 13 May 2024
in Cancer Cell Signaling
Systematic Review
Published on 01 May 2024
in Cancer Cell Signaling
Mini Review
Published on 26 Apr 2024
in Cancer Cell Signaling
Review
Published on 15 Apr 2024
in Cancer Cell Signaling
Original Research
Accepted on 12 Apr 2024
in Cancer Cell Signaling
Review
Published on 05 Apr 2024
in Cancer Cell Signaling
Review
Published on 02 Apr 2024
in Cancer Cell Signaling
Review
Published on 27 Sep 2023
in Cancer Cell Signaling
Review
Published on 11 Sep 2023
in Cancer Cell Signaling
Review
Published on 27 Jul 2023
in Cancer Cell Signaling
Review
Published on 26 Apr 2023
in Cancer Cell Signaling